Pennington Biomedical Research Center

Running trials

• Not yet recruiting

  Continuous Glucose Monitoring in Metabolic Surgery

  NCT07095972· Pennington Biomedical Research Center· Source

• Not yet recruiting

  Ability of Almonds to Improve Nutrition During GLP-1 Treatment

  NCT07796204· Pennington Biomedical Research Center· Source

• Recruiting

  A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  NCT07794579· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Phentermine's Impact on Treatment in Teens

  NCT07282340· Phase 2· Russell McCulloh, MD· Source

• Recruiting

  Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  NCT07575399· Phase 3· Amgen· Source

• Recruiting

  Body Composition Outcomes in MS Patients

  NCT07530718· Pennington Biomedical Research Center· Source

• Active, not recruiting

  Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

  NCT07446998· Phase 2· Veru Inc.· Source

• Active, not recruiting

  Ultra-processed Food Consumption and Health Pilot Study

  NCT07318064· Pennington Biomedical Research Center· Source

• Recruiting

  Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition

  NCT07265323· Pennington Biomedical Research Center· Source

• Recruiting

  GLP-1R Actions on Muscle and the Skeleton

  NCT07154719· Phase 4· Pennington Biomedical Research Center· Source

• Recruiting

  Impact of Lean Pork on Endothelial Function in Perimenopause

  NCT06976112· Pennington Biomedical Research Center· Source

• Recruiting

  Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants

  NCT07096011· Pennington Biomedical Research Center· Source

• Active, not recruiting

  A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity

  NCT06745284· Phase 1· Boehringer Ingelheim· Source

• Active, not recruiting

  A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

  NCT06859268· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Pennington Generation Cohort

  NCT06849206· Pennington Biomedical Research Center· Source

• Recruiting

  The Dose Trial: Dose Intensity of Behavioral Interventions for Childhood Obesity

  NCT06654323· Vanderbilt University Medical Center· Source

• Recruiting

  Experimental Approach to Test Predictions of Body Weight Regulation Models

  NCT06309576· Pennington Biomedical Research Center· Source

• Active, not recruiting

  A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

  NCT06662383· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise

  NCT06602141· AdventHealth Translational Research Institute· Source

• Recruiting

  Nutrition for Asthmatics

  NCT06151405· Pennington Biomedical Research Center· Source

• Active, not recruiting

  A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

  NCT06345339· Phase 2/3· AbbVie· Source

• Recruiting

  The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy

  NCT06318507· Pennington Biomedical Research Center· Source

• Active, not recruiting

  The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia

  NCT05919147· Phase 2· Pennington Biomedical Research Center· Source

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

  NCT06075667· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes

  NCT05958368· Pennington Biomedical Research Center· Source

• Active, not recruiting

  A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  NCT05869903· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Low Oxygen Exposure and Weight Status

  NCT05289310· Pennington Biomedical Research Center· Source

• Active, not recruiting

  TARGETing Healthy Weight Loss in the Context of Food Insecurity

  NCT05601804· Pennington Biomedical Research Center· Source

• Active, not recruiting

  Medication Adherence Program

  NCT05183763· Tulane University· Source

• Active, not recruiting

  Metformin in Alzheimer's Dementia Prevention

  NCT04098666· Phase 2/3· Columbia University· Source

• Recruiting

  Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

  NCT04583514· Pennington Biomedical Research Center· Source

• Recruiting

  Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"

  NCT03890861· Pennington Biomedical Research Center· Source

• Active, not recruiting

  Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)

  NCT07224347· Anne Murray· Source

• Active, not recruiting

  Dietary, Physiological, Genetic, and Behavioral Predictors of Health in a Young, Ethnically-Mixed Population

  NCT00945633· Pennington Biomedical Research Center· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity14 recruiting
• Alzheimer disease2 recruiting
• Asthma1 recruiting
• Triple-negative breast cancer1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  The Effect of Providing Genetic Risk Information on Lifestyle Behaviors in African Americans

  NCT07833384· Early phase 1· Pennington Biomedical Research Center· Source

• Completed

  Pharmacokinetics of Butyrate Tablet BKR-017

  NCT06556745· BioKier Inc.· Source

• Completed

  Iron Absorption in The Low Oxygen Exposure and Weight Status (LOWS) Study

  NCT07542873· Pennington Biomedical Research Center· Source

• Completed

  A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

  NCT06717425· Phase 2· Pfizer· Source

• Completed

  Impact of Metabolic Flexibility on Changes in Metabolic Health

  NCT06340321· Pennington Biomedical Research Center· Source

• Completed

  Military Health and Nutrition Examination Study

  NCT06380322· Pennington Biomedical Research Center· Source

• Completed

  A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943

  NCT06313528· Phase 1· Eli Lilly and Company· Source

• Completed

  Life's End Benefits of cannaBidiol and tetrahYdrocannabinol

  NCT05644262· Phase 2· University of Southern California· Source

• Completed

  Improving Glycemic Control Using a Virtual Weight Control Program and Continuous Glucose Monitoring

  NCT05935514· Pennington Biomedical Research Center· Source

• Completed

  Effects of Immulina TM Supplements With PASC Patients

  NCT05524532· Phase 3· University of Mississippi Medical Center· Source

• Terminated

  Metabolic Response to Food in Lung Cancer

  NCT05937074· Pennington Biomedical Research Center· Source

• Completed

  A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

  NCT05769608· Phase 2· Mineralys Therapeutics Inc.· Source

• Withdrawn

  Improving Glycemic Control Using a Virtual Weight Control Program Among Adults With Type 2 Diabetes

  NCT05663554· Pennington Biomedical Research Center· Source

• Completed

  Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15

  NCT05546476· Phase 2· Pfizer· Source

• Completed

  Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

  NCT05616013· Phase 2· Eli Lilly and Company· Source

• Completed

  Role Of Metabolic Adaptation In Weight Regain

  NCT05766358· Pennington Biomedical Research Center· Source

• Completed

  Promoting Successful Weight Loss in Primary Care in Louisiana Using Information Technology

  NCT05523375· Pennington Biomedical Research Center· Source

• Completed

  Nutrition for Asthmatics with Obesity

  NCT05222451· Pennington Biomedical Research Center· Source

• Completed

  Adipose Cellular Kinetics of Lipedema

  NCT05394467· Pennington Biomedical Research Center· Source

• Completed

  Effects of Using E-Cigarettes on Lungs in People With HIV (HBS Ancillary)

  NCT04794543· Pennington Biomedical Research Center· Source

• Terminated

  Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis

  NCT03587831· University of Minnesota· Source

• Completed

  Meals to Improve Absorption of Iron Supplements

  NCT04793906· Pennington Biomedical Research Center· Source

• Completed

  A Weight Maintenance Program Promoting Fat Loss in Pregnancy in Women With Obesity

  NCT04731688· Pennington Biomedical Research Center· Source

• Completed

  Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers

  NCT03843424· Washington University School of Medicine· Source

• Completed

  The Exercise And Colorectal Cancer Treatment Trial

  NCT03975491· Pennington Biomedical Research Center· Source

• Completed

  Effects of Wild Blueberry Ingestion on Motor Performance of People With Parkinson's Disease

  NCT07720869· Phase 1· Louisiana State University, Baton Rouge· Source

• Completed

  Lifestyle Intervention in Preparation for Pregnancy (LIPP)

  NCT03146156· Tufts Medical Center· Source

• Completed

  Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise

  NCT02977442· Pennington Biomedical Research Center· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Obesity144 works · 40 trials
• Gestational diabetes13 works · 0 trials
• Neurofibromatosis type 14 works · 0 trials